Persistent DNA damage‐induced premature senescence alters the functional features of human bone marrow mesenchymal stem cells

Human mesenchymal stem cells (hMSCs) are adult multipotent stem cells located in various tissues, including the bone marrow. In contrast to terminally differentiated somatic cells, adult stem cells must persist and function throughout life to ensure tissue homeostasis and repair. For this reason, th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cellular and molecular medicine 2015-04, Vol.19 (4), p.734-743
Hauptverfasser: Minieri, Valentina, Saviozzi, Silvia, Gambarotta, Giovanna, Lo Iacono, Marco, Accomasso, Lisa, Cibrario Rocchietti, Elisa, Gallina, Clara, Turinetto, Valentina, Giachino, Claudia
Format: Artikel
Sprache:eng
Schlagworte:
DNA
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 743
container_issue 4
container_start_page 734
container_title Journal of cellular and molecular medicine
container_volume 19
creator Minieri, Valentina
Saviozzi, Silvia
Gambarotta, Giovanna
Lo Iacono, Marco
Accomasso, Lisa
Cibrario Rocchietti, Elisa
Gallina, Clara
Turinetto, Valentina
Giachino, Claudia
description Human mesenchymal stem cells (hMSCs) are adult multipotent stem cells located in various tissues, including the bone marrow. In contrast to terminally differentiated somatic cells, adult stem cells must persist and function throughout life to ensure tissue homeostasis and repair. For this reason, they must be equipped with DNA damage responses able to maintain genomic integrity while ensuring their lifelong persistence. Evaluation of hMSC response to genotoxic insults is of great interest considering both their therapeutic potential and their physiological functions. This study aimed to investigate the response of human bone marrow MSCs to the genotoxic agent Actinomycin D (ActD), a well‐known anti‐tumour drug. We report that hMSCs react by undergoing premature senescence driven by a persistent DNA damage response activation, as hallmarked by inhibition of DNA synthesis, p21 and p16 protein expression, marked Senescent Associated β‐galactosidase activity and enlarged γH2AX foci co‐localizing with 53BP1 protein. Senescent hMSCs overexpress several senescence‐associated secretory phenotype (SASP) genes and promote motility of lung tumour and osteosarcoma cell lines in vitro. Our findings disclose a multifaceted consequence of ActD treatment on hMSCs that on the one hand helps to preserve this stem cell pool and prevents damaged cells from undergoing neoplastic transformation, and on the other hand alters their functional effects on the surrounding tissue microenvironment in a way that might worsen their tumour‐promoting behaviour.
doi_str_mv 10.1111/jcmm.12387
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4395188</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1668240580</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5187-ea72ee577e6423fe6c71d52f4f86fb87615e1e3923b388019b00d4488fa80eb63</originalsourceid><addsrcrecordid>eNp9kU1vFCEch0mjsbX10g_QkHgxJlt5mWHgYtJsfU1bPeiZMMyf7mwGWGGmzZ70I_gZ_SSy3bWpHuQCCQ8PP_ghdEzJKS3j1dJ6f0oZl80eOqC1ZLNK8erRbk0ll_voac5LQrigXD1B-6wWVDVcHKDvnyHlPo8QRnx-dYY74801_Prxsw_dZKHDqwTejFMCnCFAthAsYDOM5RgeF4DdFOzYx2AG7OAOzDg6vJi8CbiNAbA3KcVb7KEI7GLtC1nu89jCMOQj9NiZIcOz3XyIvr5982X-fnbx6d2H-dnFzNZUNjMwDQOomwZExbgDYRva1cxVTgrXykbQGihwxXjLpSRUtYR0VSWlM5JAK_gher31rqbWQ1eeMSYz6FXqS7y1jqbXf--EfqGv442uuCoJZBG82AlS_DZBHrXv8-YJJkCcsqZCSFaRWpKCPv8HXcYplR_KmjFFWFEqVaiXW8qmmHMCdx-GEr3pVW961Xe9FvjkYfx79E-RBaBb4LYfYP0flf44v7zcSn8DTVKxaw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2290243999</pqid></control><display><type>article</type><title>Persistent DNA damage‐induced premature senescence alters the functional features of human bone marrow mesenchymal stem cells</title><source>MEDLINE</source><source>Wiley Online Library Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Minieri, Valentina ; Saviozzi, Silvia ; Gambarotta, Giovanna ; Lo Iacono, Marco ; Accomasso, Lisa ; Cibrario Rocchietti, Elisa ; Gallina, Clara ; Turinetto, Valentina ; Giachino, Claudia</creator><creatorcontrib>Minieri, Valentina ; Saviozzi, Silvia ; Gambarotta, Giovanna ; Lo Iacono, Marco ; Accomasso, Lisa ; Cibrario Rocchietti, Elisa ; Gallina, Clara ; Turinetto, Valentina ; Giachino, Claudia</creatorcontrib><description>Human mesenchymal stem cells (hMSCs) are adult multipotent stem cells located in various tissues, including the bone marrow. In contrast to terminally differentiated somatic cells, adult stem cells must persist and function throughout life to ensure tissue homeostasis and repair. For this reason, they must be equipped with DNA damage responses able to maintain genomic integrity while ensuring their lifelong persistence. Evaluation of hMSC response to genotoxic insults is of great interest considering both their therapeutic potential and their physiological functions. This study aimed to investigate the response of human bone marrow MSCs to the genotoxic agent Actinomycin D (ActD), a well‐known anti‐tumour drug. We report that hMSCs react by undergoing premature senescence driven by a persistent DNA damage response activation, as hallmarked by inhibition of DNA synthesis, p21 and p16 protein expression, marked Senescent Associated β‐galactosidase activity and enlarged γH2AX foci co‐localizing with 53BP1 protein. Senescent hMSCs overexpress several senescence‐associated secretory phenotype (SASP) genes and promote motility of lung tumour and osteosarcoma cell lines in vitro. Our findings disclose a multifaceted consequence of ActD treatment on hMSCs that on the one hand helps to preserve this stem cell pool and prevents damaged cells from undergoing neoplastic transformation, and on the other hand alters their functional effects on the surrounding tissue microenvironment in a way that might worsen their tumour‐promoting behaviour.</description><identifier>ISSN: 1582-1838</identifier><identifier>EISSN: 1582-4934</identifier><identifier>DOI: 10.1111/jcmm.12387</identifier><identifier>PMID: 25619736</identifier><language>eng</language><publisher>England: John Wiley &amp; Sons, Inc</publisher><subject>Actinomycin ; actinomycin D ; Amino acids ; Antibiotics, Antineoplastic - pharmacology ; Apoptosis ; beta-Galactosidase - metabolism ; Bone cancer ; Bone marrow ; Cancer therapies ; Cell cycle ; Cell differentiation ; Cell Differentiation - drug effects ; Cell Differentiation - genetics ; Cell Line, Tumor ; Cell lines ; Cell Survival - drug effects ; Cell Survival - genetics ; Cells, Cultured ; Cellular Senescence - drug effects ; Cellular Senescence - genetics ; Chemotherapy ; Cyclin-Dependent Kinase Inhibitor p16 - metabolism ; Cyclin-Dependent Kinase Inhibitor p21 - metabolism ; Dactinomycin - pharmacology ; Damage prevention ; Data analysis ; Deoxyribonucleic acid ; DNA ; DNA - genetics ; DNA - metabolism ; DNA biosynthesis ; DNA Damage ; DNA repair ; Galactosidase ; Gene Expression - drug effects ; Genetic transformation ; Genotoxic chemicals ; Genotoxicity ; GTP-binding protein ; Histones - metabolism ; Homeostasis ; Human behavior ; Humans ; Immunoblotting ; Interleukin-6 - genetics ; Interleukin-8 - genetics ; Intracellular Signaling Peptides and Proteins - metabolism ; Lung cancer ; Lungs ; Lymphocytes ; mesenchymal stem cell ; Mesenchymal stem cells ; Mesenchymal Stem Cells - drug effects ; Mesenchymal Stem Cells - metabolism ; Mesenchyme ; Microscopy, Confocal ; Original ; Osteosarcoma ; p16 Protein ; Phenotypes ; Physiology ; Protein biosynthesis ; Reverse Transcriptase Polymerase Chain Reaction ; Sarcoma ; Senescence ; senescence‐associated secretory phenotype ; Somatic cells ; Stem cells ; stress‐induced premature senescence ; Tissues ; Tumor cell lines ; Tumor Suppressor p53-Binding Protein 1 ; Tumors ; β-Galactosidase</subject><ispartof>Journal of cellular and molecular medicine, 2015-04, Vol.19 (4), p.734-743</ispartof><rights>2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley &amp; Sons Ltd and Foundation for Cellular and Molecular Medicine.</rights><rights>2015. This work is published under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley &amp; Sons Ltd and Foundation for Cellular and Molecular Medicine. 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5187-ea72ee577e6423fe6c71d52f4f86fb87615e1e3923b388019b00d4488fa80eb63</citedby><cites>FETCH-LOGICAL-c5187-ea72ee577e6423fe6c71d52f4f86fb87615e1e3923b388019b00d4488fa80eb63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395188/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395188/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,1411,11543,27903,27904,45553,45554,46030,46454,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25619736$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Minieri, Valentina</creatorcontrib><creatorcontrib>Saviozzi, Silvia</creatorcontrib><creatorcontrib>Gambarotta, Giovanna</creatorcontrib><creatorcontrib>Lo Iacono, Marco</creatorcontrib><creatorcontrib>Accomasso, Lisa</creatorcontrib><creatorcontrib>Cibrario Rocchietti, Elisa</creatorcontrib><creatorcontrib>Gallina, Clara</creatorcontrib><creatorcontrib>Turinetto, Valentina</creatorcontrib><creatorcontrib>Giachino, Claudia</creatorcontrib><title>Persistent DNA damage‐induced premature senescence alters the functional features of human bone marrow mesenchymal stem cells</title><title>Journal of cellular and molecular medicine</title><addtitle>J Cell Mol Med</addtitle><description>Human mesenchymal stem cells (hMSCs) are adult multipotent stem cells located in various tissues, including the bone marrow. In contrast to terminally differentiated somatic cells, adult stem cells must persist and function throughout life to ensure tissue homeostasis and repair. For this reason, they must be equipped with DNA damage responses able to maintain genomic integrity while ensuring their lifelong persistence. Evaluation of hMSC response to genotoxic insults is of great interest considering both their therapeutic potential and their physiological functions. This study aimed to investigate the response of human bone marrow MSCs to the genotoxic agent Actinomycin D (ActD), a well‐known anti‐tumour drug. We report that hMSCs react by undergoing premature senescence driven by a persistent DNA damage response activation, as hallmarked by inhibition of DNA synthesis, p21 and p16 protein expression, marked Senescent Associated β‐galactosidase activity and enlarged γH2AX foci co‐localizing with 53BP1 protein. Senescent hMSCs overexpress several senescence‐associated secretory phenotype (SASP) genes and promote motility of lung tumour and osteosarcoma cell lines in vitro. Our findings disclose a multifaceted consequence of ActD treatment on hMSCs that on the one hand helps to preserve this stem cell pool and prevents damaged cells from undergoing neoplastic transformation, and on the other hand alters their functional effects on the surrounding tissue microenvironment in a way that might worsen their tumour‐promoting behaviour.</description><subject>Actinomycin</subject><subject>actinomycin D</subject><subject>Amino acids</subject><subject>Antibiotics, Antineoplastic - pharmacology</subject><subject>Apoptosis</subject><subject>beta-Galactosidase - metabolism</subject><subject>Bone cancer</subject><subject>Bone marrow</subject><subject>Cancer therapies</subject><subject>Cell cycle</subject><subject>Cell differentiation</subject><subject>Cell Differentiation - drug effects</subject><subject>Cell Differentiation - genetics</subject><subject>Cell Line, Tumor</subject><subject>Cell lines</subject><subject>Cell Survival - drug effects</subject><subject>Cell Survival - genetics</subject><subject>Cells, Cultured</subject><subject>Cellular Senescence - drug effects</subject><subject>Cellular Senescence - genetics</subject><subject>Chemotherapy</subject><subject>Cyclin-Dependent Kinase Inhibitor p16 - metabolism</subject><subject>Cyclin-Dependent Kinase Inhibitor p21 - metabolism</subject><subject>Dactinomycin - pharmacology</subject><subject>Damage prevention</subject><subject>Data analysis</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>DNA - genetics</subject><subject>DNA - metabolism</subject><subject>DNA biosynthesis</subject><subject>DNA Damage</subject><subject>DNA repair</subject><subject>Galactosidase</subject><subject>Gene Expression - drug effects</subject><subject>Genetic transformation</subject><subject>Genotoxic chemicals</subject><subject>Genotoxicity</subject><subject>GTP-binding protein</subject><subject>Histones - metabolism</subject><subject>Homeostasis</subject><subject>Human behavior</subject><subject>Humans</subject><subject>Immunoblotting</subject><subject>Interleukin-6 - genetics</subject><subject>Interleukin-8 - genetics</subject><subject>Intracellular Signaling Peptides and Proteins - metabolism</subject><subject>Lung cancer</subject><subject>Lungs</subject><subject>Lymphocytes</subject><subject>mesenchymal stem cell</subject><subject>Mesenchymal stem cells</subject><subject>Mesenchymal Stem Cells - drug effects</subject><subject>Mesenchymal Stem Cells - metabolism</subject><subject>Mesenchyme</subject><subject>Microscopy, Confocal</subject><subject>Original</subject><subject>Osteosarcoma</subject><subject>p16 Protein</subject><subject>Phenotypes</subject><subject>Physiology</subject><subject>Protein biosynthesis</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>Sarcoma</subject><subject>Senescence</subject><subject>senescence‐associated secretory phenotype</subject><subject>Somatic cells</subject><subject>Stem cells</subject><subject>stress‐induced premature senescence</subject><subject>Tissues</subject><subject>Tumor cell lines</subject><subject>Tumor Suppressor p53-Binding Protein 1</subject><subject>Tumors</subject><subject>β-Galactosidase</subject><issn>1582-1838</issn><issn>1582-4934</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kU1vFCEch0mjsbX10g_QkHgxJlt5mWHgYtJsfU1bPeiZMMyf7mwGWGGmzZ70I_gZ_SSy3bWpHuQCCQ8PP_ghdEzJKS3j1dJ6f0oZl80eOqC1ZLNK8erRbk0ll_voac5LQrigXD1B-6wWVDVcHKDvnyHlPo8QRnx-dYY74801_Prxsw_dZKHDqwTejFMCnCFAthAsYDOM5RgeF4DdFOzYx2AG7OAOzDg6vJi8CbiNAbA3KcVb7KEI7GLtC1nu89jCMOQj9NiZIcOz3XyIvr5982X-fnbx6d2H-dnFzNZUNjMwDQOomwZExbgDYRva1cxVTgrXykbQGihwxXjLpSRUtYR0VSWlM5JAK_gher31rqbWQ1eeMSYz6FXqS7y1jqbXf--EfqGv442uuCoJZBG82AlS_DZBHrXv8-YJJkCcsqZCSFaRWpKCPv8HXcYplR_KmjFFWFEqVaiXW8qmmHMCdx-GEr3pVW961Xe9FvjkYfx79E-RBaBb4LYfYP0flf44v7zcSn8DTVKxaw</recordid><startdate>201504</startdate><enddate>201504</enddate><creator>Minieri, Valentina</creator><creator>Saviozzi, Silvia</creator><creator>Gambarotta, Giovanna</creator><creator>Lo Iacono, Marco</creator><creator>Accomasso, Lisa</creator><creator>Cibrario Rocchietti, Elisa</creator><creator>Gallina, Clara</creator><creator>Turinetto, Valentina</creator><creator>Giachino, Claudia</creator><general>John Wiley &amp; Sons, Inc</general><general>BlackWell Publishing Ltd</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201504</creationdate><title>Persistent DNA damage‐induced premature senescence alters the functional features of human bone marrow mesenchymal stem cells</title><author>Minieri, Valentina ; Saviozzi, Silvia ; Gambarotta, Giovanna ; Lo Iacono, Marco ; Accomasso, Lisa ; Cibrario Rocchietti, Elisa ; Gallina, Clara ; Turinetto, Valentina ; Giachino, Claudia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5187-ea72ee577e6423fe6c71d52f4f86fb87615e1e3923b388019b00d4488fa80eb63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Actinomycin</topic><topic>actinomycin D</topic><topic>Amino acids</topic><topic>Antibiotics, Antineoplastic - pharmacology</topic><topic>Apoptosis</topic><topic>beta-Galactosidase - metabolism</topic><topic>Bone cancer</topic><topic>Bone marrow</topic><topic>Cancer therapies</topic><topic>Cell cycle</topic><topic>Cell differentiation</topic><topic>Cell Differentiation - drug effects</topic><topic>Cell Differentiation - genetics</topic><topic>Cell Line, Tumor</topic><topic>Cell lines</topic><topic>Cell Survival - drug effects</topic><topic>Cell Survival - genetics</topic><topic>Cells, Cultured</topic><topic>Cellular Senescence - drug effects</topic><topic>Cellular Senescence - genetics</topic><topic>Chemotherapy</topic><topic>Cyclin-Dependent Kinase Inhibitor p16 - metabolism</topic><topic>Cyclin-Dependent Kinase Inhibitor p21 - metabolism</topic><topic>Dactinomycin - pharmacology</topic><topic>Damage prevention</topic><topic>Data analysis</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>DNA - genetics</topic><topic>DNA - metabolism</topic><topic>DNA biosynthesis</topic><topic>DNA Damage</topic><topic>DNA repair</topic><topic>Galactosidase</topic><topic>Gene Expression - drug effects</topic><topic>Genetic transformation</topic><topic>Genotoxic chemicals</topic><topic>Genotoxicity</topic><topic>GTP-binding protein</topic><topic>Histones - metabolism</topic><topic>Homeostasis</topic><topic>Human behavior</topic><topic>Humans</topic><topic>Immunoblotting</topic><topic>Interleukin-6 - genetics</topic><topic>Interleukin-8 - genetics</topic><topic>Intracellular Signaling Peptides and Proteins - metabolism</topic><topic>Lung cancer</topic><topic>Lungs</topic><topic>Lymphocytes</topic><topic>mesenchymal stem cell</topic><topic>Mesenchymal stem cells</topic><topic>Mesenchymal Stem Cells - drug effects</topic><topic>Mesenchymal Stem Cells - metabolism</topic><topic>Mesenchyme</topic><topic>Microscopy, Confocal</topic><topic>Original</topic><topic>Osteosarcoma</topic><topic>p16 Protein</topic><topic>Phenotypes</topic><topic>Physiology</topic><topic>Protein biosynthesis</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>Sarcoma</topic><topic>Senescence</topic><topic>senescence‐associated secretory phenotype</topic><topic>Somatic cells</topic><topic>Stem cells</topic><topic>stress‐induced premature senescence</topic><topic>Tissues</topic><topic>Tumor cell lines</topic><topic>Tumor Suppressor p53-Binding Protein 1</topic><topic>Tumors</topic><topic>β-Galactosidase</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Minieri, Valentina</creatorcontrib><creatorcontrib>Saviozzi, Silvia</creatorcontrib><creatorcontrib>Gambarotta, Giovanna</creatorcontrib><creatorcontrib>Lo Iacono, Marco</creatorcontrib><creatorcontrib>Accomasso, Lisa</creatorcontrib><creatorcontrib>Cibrario Rocchietti, Elisa</creatorcontrib><creatorcontrib>Gallina, Clara</creatorcontrib><creatorcontrib>Turinetto, Valentina</creatorcontrib><creatorcontrib>Giachino, Claudia</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of cellular and molecular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Minieri, Valentina</au><au>Saviozzi, Silvia</au><au>Gambarotta, Giovanna</au><au>Lo Iacono, Marco</au><au>Accomasso, Lisa</au><au>Cibrario Rocchietti, Elisa</au><au>Gallina, Clara</au><au>Turinetto, Valentina</au><au>Giachino, Claudia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Persistent DNA damage‐induced premature senescence alters the functional features of human bone marrow mesenchymal stem cells</atitle><jtitle>Journal of cellular and molecular medicine</jtitle><addtitle>J Cell Mol Med</addtitle><date>2015-04</date><risdate>2015</risdate><volume>19</volume><issue>4</issue><spage>734</spage><epage>743</epage><pages>734-743</pages><issn>1582-1838</issn><eissn>1582-4934</eissn><abstract>Human mesenchymal stem cells (hMSCs) are adult multipotent stem cells located in various tissues, including the bone marrow. In contrast to terminally differentiated somatic cells, adult stem cells must persist and function throughout life to ensure tissue homeostasis and repair. For this reason, they must be equipped with DNA damage responses able to maintain genomic integrity while ensuring their lifelong persistence. Evaluation of hMSC response to genotoxic insults is of great interest considering both their therapeutic potential and their physiological functions. This study aimed to investigate the response of human bone marrow MSCs to the genotoxic agent Actinomycin D (ActD), a well‐known anti‐tumour drug. We report that hMSCs react by undergoing premature senescence driven by a persistent DNA damage response activation, as hallmarked by inhibition of DNA synthesis, p21 and p16 protein expression, marked Senescent Associated β‐galactosidase activity and enlarged γH2AX foci co‐localizing with 53BP1 protein. Senescent hMSCs overexpress several senescence‐associated secretory phenotype (SASP) genes and promote motility of lung tumour and osteosarcoma cell lines in vitro. Our findings disclose a multifaceted consequence of ActD treatment on hMSCs that on the one hand helps to preserve this stem cell pool and prevents damaged cells from undergoing neoplastic transformation, and on the other hand alters their functional effects on the surrounding tissue microenvironment in a way that might worsen their tumour‐promoting behaviour.</abstract><cop>England</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>25619736</pmid><doi>10.1111/jcmm.12387</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1582-1838
ispartof Journal of cellular and molecular medicine, 2015-04, Vol.19 (4), p.734-743
issn 1582-1838
1582-4934
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4395188
source MEDLINE; Wiley Online Library Open Access; DOAJ Directory of Open Access Journals; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Actinomycin
actinomycin D
Amino acids
Antibiotics, Antineoplastic - pharmacology
Apoptosis
beta-Galactosidase - metabolism
Bone cancer
Bone marrow
Cancer therapies
Cell cycle
Cell differentiation
Cell Differentiation - drug effects
Cell Differentiation - genetics
Cell Line, Tumor
Cell lines
Cell Survival - drug effects
Cell Survival - genetics
Cells, Cultured
Cellular Senescence - drug effects
Cellular Senescence - genetics
Chemotherapy
Cyclin-Dependent Kinase Inhibitor p16 - metabolism
Cyclin-Dependent Kinase Inhibitor p21 - metabolism
Dactinomycin - pharmacology
Damage prevention
Data analysis
Deoxyribonucleic acid
DNA
DNA - genetics
DNA - metabolism
DNA biosynthesis
DNA Damage
DNA repair
Galactosidase
Gene Expression - drug effects
Genetic transformation
Genotoxic chemicals
Genotoxicity
GTP-binding protein
Histones - metabolism
Homeostasis
Human behavior
Humans
Immunoblotting
Interleukin-6 - genetics
Interleukin-8 - genetics
Intracellular Signaling Peptides and Proteins - metabolism
Lung cancer
Lungs
Lymphocytes
mesenchymal stem cell
Mesenchymal stem cells
Mesenchymal Stem Cells - drug effects
Mesenchymal Stem Cells - metabolism
Mesenchyme
Microscopy, Confocal
Original
Osteosarcoma
p16 Protein
Phenotypes
Physiology
Protein biosynthesis
Reverse Transcriptase Polymerase Chain Reaction
Sarcoma
Senescence
senescence‐associated secretory phenotype
Somatic cells
Stem cells
stress‐induced premature senescence
Tissues
Tumor cell lines
Tumor Suppressor p53-Binding Protein 1
Tumors
β-Galactosidase
title Persistent DNA damage‐induced premature senescence alters the functional features of human bone marrow mesenchymal stem cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T16%3A11%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Persistent%20DNA%20damage%E2%80%90induced%20premature%20senescence%20alters%20the%20functional%20features%20of%20human%20bone%20marrow%20mesenchymal%20stem%20cells&rft.jtitle=Journal%20of%20cellular%20and%20molecular%20medicine&rft.au=Minieri,%20Valentina&rft.date=2015-04&rft.volume=19&rft.issue=4&rft.spage=734&rft.epage=743&rft.pages=734-743&rft.issn=1582-1838&rft.eissn=1582-4934&rft_id=info:doi/10.1111/jcmm.12387&rft_dat=%3Cproquest_pubme%3E1668240580%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2290243999&rft_id=info:pmid/25619736&rfr_iscdi=true